Loading
Latest filing published 05 Jun 2023 for CLINICA BAVIERA, S.A., €8,348.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Eduardo Baviera Diaz Leante appears in our data through filings on Clinica Baviera, S.A. shares, published by CNMV. Over a trading history stretching from 9 November 2022 to 1 June 2023, the count stands at 5 filings.
No open-market sale appears; the market trades are 5 purchases worth €26k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2023, the count stands at 2 purchases and no sales.
A typical purchase (the median) is worth €5,022. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 5 June 2023 came the latest disclosure, an open-market purchase for €8,348 in Clinica Baviera, S.A. The median gap between a trade and its publication by CNMV is 3 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by CNMV. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations